| 摘要 |
Pyrazolo-quinazoline derivatives of formula (Ia) or (Ib) as defined in the specification, and pharmeceutically acceptable salts thereof, process for their preparation and pharmaceutical composition comprising them are disclosed; the compounds of the invention maybe useful in therapy, in the treatment of diseases associated with a disregulated protein kinase activity, like cancer. |
